Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Here's What This Label Expansion Could Mean for Eli Lilly Investors
Here's What This Label Expansion Could Mean for Eli Lilly Investors
Here's What This Label Expansion Could Mean for Eli Lilly Investors
Submitted by
admin
on August 29, 2021 - 11:16pm
Source:
Motley Fool
News Tags:
Eli Lilly
Jardiance
heart failure
label expansions
FDA
Headline:
Here's What This Label Expansion Could Mean for Eli Lilly Investors
snippet:
Through its latest FDA approval, Jardiance can now access a multibillion-dollar heart failure market.
Establishing its own niche in this large market could bring Eli Lilly significant additional annual revenue.
Helped as well by other products, Eli Lilly could see mid-teen annual earnings growth over the next five years.
Do Not Allow Advertisers to Use My Personal information
